Data Independent Acquisition Reveals In-Depth Serum Proteome Changes in Canine Leishmaniosis [PDF]
Metabolites, 2023 Comprehensive profiling of serum proteome provides valuable clues of health status and pathophysiological processes, making it the main strategy in biomarker discovery.
Franjo Martinković +5 more
doaj +2 more sources
Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy [PDF]
Parasites & Vectors, 2023 Background Leishmania infantum is an intracellular protozoan parasite which is endemic in countries of the Mediterranean Basin. Leishmaniosis is increasingly diagnosed in non-endemic areas due to the relocation of dogs from endemic areas and the travel ...
Marja Klazina de Jong +3 more
doaj +2 more sources
Canine leishmaniosis in Tunisia: Growing prevalence, larger zones of infection. [PDF]
PLoS Neglected Tropical Diseases, 2021 BackgroundDiscovered by Nicolle and Comte in 1908 in Tunisia, Leishmania infantum is an intracellular protozoan responsible for zoonotic canine leishmaniosis (CanL) and zoonotic human visceral leishmaniasis (HVL).
Ali Bouattour +6 more
doaj +4 more sources
Is pancreatitis associated with meglumine antimoniate treatment for canine leishmaniosis? A multicentric prospective study [PDF]
Parasites & VectorsBackground Meglumine antimoniate is used to treat canine leishmaniosis. In humans, it has been associated with pancreatitis. Although a few case reports have described acute pancreatitis secondary to antimonial treatment in dogs, some studies have ...
Clàudia Viñeta +6 more
doaj +2 more sources
Retrospective study of canine leishmaniosis in Israel [PDF]
Parasites & VectorsBackground Canine and human leishmaniasis are prevalent around the Mediterranean Basin, where dogs are considered to be the main peridomestic reservoir for human disease. Canine leishmaniosis was initially diagnosed in central Israel in 1994. Since then,
Gad Baneth +5 more
doaj +2 more sources
Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis [PDF]
Pathogens, 2023 Miltefosine-Allopurinol (MIL-AL) combination is reported to be one of the most effective treatments for canine leishmaniosis, thanks to its oral administration and MIL-documented low impact on renal function. However, MIL-AL is considered a second-choice
Manuela Gizzarelli +4 more
doaj +2 more sources
Trends and Gaps in the Scientific Literature about the Effects of Nutritional Supplements on Canine Leishmaniosis [PDF]
PathogensIn canine leishmaniosis (CanL), complex interactions between the parasites and the immunological background of the host influence the clinical presentation and evolution of infection and disease.
Annalisa Previti +4 more
doaj +2 more sources
Canine Leishmaniosis Control through the Promotion of Preventive Measures Appropriately Adopted by Citizens [PDF]
Journal of Parasitology Research, 2020 Canine leishmaniosis (CanL) is a disease caused by the protist Leishmania infantum and transmitted to dogs by sand fly (Diptera: Phlebotominae) bites.
Giulia Simonato +9 more
doaj +2 more sources
Prognostic Factors and Life Expectancy in Canine Leishmaniosis [PDF]
Veterinary Sciences, 2020 Canine leishmaniosis (CanL) is a chronic and potentially fatal disease. The prognosis of CanL depends on the severity of the clinical signs and clinicopathological abnormalities presented by the dog at the time of diagnosis.
Maria Aires Pereira +8 more
doaj +2 more sources
Short communication. Molecular evidence of Leishmania infantum in Ixodes ricinus ticks from dogs and cats, in Italy [PDF]
Veterinaria Italiana, 2014 Leishmaniosis, caused by Leishmania infantum, is an endemic zoonosis in the Mediterranean basin. To date, phlebotomine sand flies are the only accepted biological vectors of Leishmania parasites to dogs and humans.
Daniela Salvatore +5 more
doaj +1 more source